Atlas Trials

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory

Clinical trial NCT06429670 · COMPLETED

Trial details

NCT number
NCT06429670
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2023-05-01
Primary completion
2023-07-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.